A TWiV duo reviews how SARS-CoV-2 attacks the olfactory mucosa but spares the olfactory bulb, vaccination with BNT162b2 induces virus-specific stem cell memory T cells, and development of an oral protease inhibitor for the treatment of COVID-19.
Click arrow to play
Download TWiV 829 (67 MB .mp3, 112 min)
Subscribe (free): iTunes, Google Podcasts, RSS, email
Show notes at microbe.tv/twiv